DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLOâ„¢, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This ...
DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12 th National Conference, which ...
The prescribed dosage for Hizentra (immune globulin subcutaneous [human]) may vary depending on an individual’s treatment plan. Other factors, including your specific diagnosis, body weight, and ...
In an effort to help improve patient lives, Advanced Infusion Care (AIC), a division of AIS Healthcare, has embarked on a joint study with Grifols, a leading global provider of essential ...
Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results